Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Characterization of monoamine oxidase activity during early stages of quail embryogenesis.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Pintar JE, Maxwell GD, Breakefield XO.
PMID: 24875606
Int J Dev Neurosci. 1983;1(1):49-57. doi: 10.1016/0736-5748(83)90010-2.

Catecholamines and other biogenic amines may play a role in early embryogenesis in addition to functioning as neurotransmitters after neuronal differentiation. Regulation of amine levels is mediated by several different parameters including activity levels of degradative enzymes. Since monoamine...

Cite
Pintar JE, Maxwell GD, Breakefield XO. Characterization of monoamine oxidase activity during early stages of quail embryogenesis. Int J Dev Neurosci. 1983;1(1):49-57doi: 10.1016/0736-5748(83)90010-2.
Pintar, J. E., Maxwell, G. D., & Breakefield, X. O. (1983). Characterization of monoamine oxidase activity during early stages of quail embryogenesis. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 1(1), 49-57. https://doi.org/10.1016/0736-5748(83)90010-2
Pintar, J E, et al. "Characterization of monoamine oxidase activity during early stages of quail embryogenesis." International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience vol. 1,1 (1983): 49-57. doi: https://doi.org/10.1016/0736-5748(83)90010-2
Pintar JE, Maxwell GD, Breakefield XO. Characterization of monoamine oxidase activity during early stages of quail embryogenesis. Int J Dev Neurosci. 1983;1(1):49-57. doi: 10.1016/0736-5748(83)90010-2. PMID: 24875606.
Copy Download .nbib Format: NLM
Both zimelidine and clorgyline decrease preprotachykinin mRNA in adult medullary raphe nuclei.

Molecular and cellular neurosciences

Riley LA, Hart RP, Jonakait GM.
PMID: 19912792
Mol Cell Neurosci. 1991 Apr;2(2):139-44. doi: 10.1016/1044-7431(91)90006-a.

Neurons of the medullary raphe nuclei contain multiple neurotransmitters including the monoamine neurotransmitter serotonin (5-HT) and the tachykinin substance P (SP). Previously, we showed that inhibition of serotonin synthesis increased levels of mRNA coding for preprotachykinin (PPT), the prohormone...

Cite
Riley LA, Hart RP, Jonakait GM. Both zimelidine and clorgyline decrease preprotachykinin mRNA in adult medullary raphe nuclei. Mol Cell Neurosci. 1991;2(2):139-44doi: 10.1016/1044-7431(91)90006-a.
Riley, L. A., Hart, R. P., & Jonakait, G. M. (1991). Both zimelidine and clorgyline decrease preprotachykinin mRNA in adult medullary raphe nuclei. Molecular and cellular neurosciences, 2(2), 139-44. https://doi.org/10.1016/1044-7431(91)90006-a
Riley, L A, et al. "Both zimelidine and clorgyline decrease preprotachykinin mRNA in adult medullary raphe nuclei." Molecular and cellular neurosciences vol. 2,2 (1991): 139-44. doi: https://doi.org/10.1016/1044-7431(91)90006-a
Riley LA, Hart RP, Jonakait GM. Both zimelidine and clorgyline decrease preprotachykinin mRNA in adult medullary raphe nuclei. Mol Cell Neurosci. 1991 Apr;2(2):139-44. doi: 10.1016/1044-7431(91)90006-a. PMID: 19912792.
Copy Download .nbib Format: NLM
Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography.

Oncology reports

Goller L, Bergstrom M, Nilsson S, Westerberg G, Langstrom B.
PMID: 21597803
Oncol Rep. 1995 Sep;2(5):717-21. doi: 10.3892/or.2.5.717.

Operative specimens from 7 patients with urinary bladder cancer and with only inflammatory tissue in the operative sample from one patient, were used for frozen section autoradiography using [C-11]harmine to characterize the expression of the enzyme monoamine oxidase A...

Cite
Goller L, Bergstrom M, Nilsson S, et al. Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography. Oncol Rep. 1995;2(5):717-21doi: 10.3892/or.2.5.717.
Goller, L., Bergstrom, M., Nilsson, S., Westerberg, G., & Langstrom, B. (1995). Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography. Oncology reports, 2(5), 717-21. https://doi.org/10.3892/or.2.5.717
Goller, L, et al. "Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography." Oncology reports vol. 2,5 (1995): 717-21. doi: https://doi.org/10.3892/or.2.5.717
Goller L, Bergstrom M, Nilsson S, Westerberg G, Langstrom B. Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography. Oncol Rep. 1995 Sep;2(5):717-21. doi: 10.3892/or.2.5.717. PMID: 21597803.
Copy Download .nbib Format: NLM
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.

Drug target insights

Kitanaka J, Kitanaka N, Takemura M.
PMID: 21901055
Drug Target Insights. 2006;1:19-28. Epub 2006 Nov 09.

Methamphetamine (METH) abuse is a serious health and social problem worldwide. At present, however, there are no effective medications for the treatment of METH abuse. Of the intracellular METH target proteins, monoamine oxidase (MAO) is involved in the regulation...

Cite
Kitanaka J, Kitanaka N, Takemura M. Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions. Drug Target Insights. 2006;1:19-28
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006). Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions. Drug target insights, 119-28.
Kitanaka, Junichi, et al. "Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions." Drug target insights vol. 1 (2006): 19-28.
Kitanaka J, Kitanaka N, Takemura M. Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions. Drug Target Insights. 2006;1:19-28. Epub 2006 Nov 09. PMID: 21901055; PMCID: PMC3155216.
Copy Download .nbib Format: NLM
Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells.

Environmental toxicology and pharmacology

Willets JM, Lambert DG, Lunec J, Griffiths HR, Phillipson O.
PMID: 21781702
Environ Toxicol Pharmacol. 1996 Aug 15;2(1):59-68. doi: 10.1016/1382-6689(96)00030-0.

We have investigated the potential neurotoxicity of the catecholamine depleting agent 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) in SH-SY5Y neuroblastoma cells. TMIQ induced a time and dose related inhibition of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; thiazoyl blue (MTT) reduction and an increase in lactate dehydrogenase release....

Cite
Willets JM, Lambert DG, Lunec J, et al. Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells. Environ Toxicol Pharmacol. 1996;2(1):59-68doi: 10.1016/1382-6689(96)00030-0.
Willets, J. M., Lambert, D. G., Lunec, J., Griffiths, H. R., & Phillipson, O. (1996). Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells. Environmental toxicology and pharmacology, 2(1), 59-68. https://doi.org/10.1016/1382-6689(96)00030-0
Willets, J M, et al. "Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells." Environmental toxicology and pharmacology vol. 2,1 (1996): 59-68. doi: https://doi.org/10.1016/1382-6689(96)00030-0
Willets JM, Lambert DG, Lunec J, Griffiths HR, Phillipson O. Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells. Environ Toxicol Pharmacol. 1996 Aug 15;2(1):59-68. doi: 10.1016/1382-6689(96)00030-0. PMID: 21781702.
Copy Download .nbib Format: NLM
Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels.

Acta neuropsychiatrica

Kitaichi Y, Inoue T, Nakagawa S, Boku S, Koyama T.
PMID: 25287180
Acta Neuropsychiatr. 2012 Dec;24(6):369-73. doi: 10.1111/j.1601-5215.2012.00652.x.

No abstract available.

Cite
Kitaichi Y, Inoue T, Nakagawa S, et al. Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels. Acta Neuropsychiatr. 2012;24(6):369-73doi: 10.1111/j.1601-5215.2012.00652.x.
Kitaichi, Y., Inoue, T., Nakagawa, S., Boku, S., & Koyama, T. (2012). Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels. Acta neuropsychiatrica, 24(6), 369-73. https://doi.org/10.1111/j.1601-5215.2012.00652.x
Kitaichi, Yuji, et al. "Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels." Acta neuropsychiatrica vol. 24,6 (2012): 369-73. doi: https://doi.org/10.1111/j.1601-5215.2012.00652.x
Kitaichi Y, Inoue T, Nakagawa S, Boku S, Koyama T. Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels. Acta Neuropsychiatr. 2012 Dec;24(6):369-73. doi: 10.1111/j.1601-5215.2012.00652.x. PMID: 25287180.
Copy Download .nbib Format: NLM
Quantification and pharmacokinetic study of tumor-targeting agent MHI148-clorgyline amide in mouse plasma using liquid chromatography-electrospray ionization tandem mass spectrometry.

Journal of pharmaceutical analysis

Wang Z, Olenyuk BZ, Shih JC, Wang J.
PMID: 29922483
J Pharm Anal. 2018 Jun;8(3):153-159. doi: 10.1016/j.jpha.2017.10.001. Epub 2017 Oct 20.

A high-performance liquid chromatography-electrospray ionization tandem mass spectrometric (HPLC-ESI-MS/MS) method was developed for the quantification of MHI148-clorgyline amide (NMI-amide), a novel tumor-targeting monoamine oxidase A inhibitor, in mouse plasma. The method was validated in terms of sensitivity, precision, accuracy,...

Cite
Wang Z, Olenyuk BZ, Shih JC, et al. Quantification and pharmacokinetic study of tumor-targeting agent MHI148-clorgyline amide in mouse plasma using liquid chromatography-electrospray ionization tandem mass spectrometry. J Pharm Anal. 2017;8(3):153-159doi: 10.1016/j.jpha.2017.10.001.
Wang, Z., Olenyuk, B. Z., Shih, J. C., & Wang, J. (2018). Quantification and pharmacokinetic study of tumor-targeting agent MHI148-clorgyline amide in mouse plasma using liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of pharmaceutical analysis, 8(3), 153-159. https://doi.org/10.1016/j.jpha.2017.10.001
Wang, Zhijun, et al. "Quantification and pharmacokinetic study of tumor-targeting agent MHI148-clorgyline amide in mouse plasma using liquid chromatography-electrospray ionization tandem mass spectrometry." Journal of pharmaceutical analysis vol. 8,3 (2018): 153-159. doi: https://doi.org/10.1016/j.jpha.2017.10.001
Wang Z, Olenyuk BZ, Shih JC, Wang J. Quantification and pharmacokinetic study of tumor-targeting agent MHI148-clorgyline amide in mouse plasma using liquid chromatography-electrospray ionization tandem mass spectrometry. J Pharm Anal. 2018 Jun;8(3):153-159. doi: 10.1016/j.jpha.2017.10.001. Epub 2017 Oct 20. PMID: 29922483; PMCID: PMC6004616.
Copy Download .nbib Format: NLM
Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice.

Evidence-based complementary and alternative medicine : eCAM

Hsu LC, Ko YJ, Cheng HY, Chang CW, Lin YC, Cheng YH, Hsieh MT, Peng WH.
PMID: 22567032
Evid Based Complement Alternat Med. 2012;2012:497302. doi: 10.1155/2012/497302. Epub 2012 Apr 09.

This study investigated the antidepressant activity of ethanolic extract of U. lanosa Wallich var. appendiculata Ridsd (UL(EtOH)) for two-weeks administrations by using FST and TST on mice. In order to understand the probable mechanism of antidepressant-like activity of UL(EtOH)...

Cite
Hsu LC, Ko YJ, Cheng HY, et al. Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice. Evid Based Complement Alternat Med. 2012;2012:497302doi: 10.1155/2012/497302.
Hsu, L. C., Ko, Y. J., Cheng, H. Y., Chang, C. W., Lin, Y. C., Cheng, Y. H., Hsieh, M. T., & Peng, W. H. (2012). Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice. Evidence-based complementary and alternative medicine : eCAM, 2012497302. https://doi.org/10.1155/2012/497302
Hsu, Lieh-Ching, et al. "Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice." Evidence-based complementary and alternative medicine : eCAM vol. 2012 (2012): 497302. doi: https://doi.org/10.1155/2012/497302
Hsu LC, Ko YJ, Cheng HY, Chang CW, Lin YC, Cheng YH, Hsieh MT, Peng WH. Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice. Evid Based Complement Alternat Med. 2012;2012:497302. doi: 10.1155/2012/497302. Epub 2012 Apr 09. PMID: 22567032; PMCID: PMC3332070.
Copy Download .nbib Format: NLM
Accumulation of Azole Drugs in the Fungal Plant Pathogen .

Frontiers in microbiology

Esquivel BD, White TC.
PMID: 28751884
Front Microbiol. 2017 Jul 13;8:1320. doi: 10.3389/fmicb.2017.01320. eCollection 2017.

No abstract available.

Cite
Esquivel BD, White TC. Accumulation of Azole Drugs in the Fungal Plant Pathogen . Front Microbiol. 2017;8:1320doi: 10.3389/fmicb.2017.01320.
Esquivel, B. D., & White, T. C. (2017). Accumulation of Azole Drugs in the Fungal Plant Pathogen . Frontiers in microbiology, 81320. https://doi.org/10.3389/fmicb.2017.01320
Esquivel, Brooke D, and White, Theodore C. "Accumulation of Azole Drugs in the Fungal Plant Pathogen ." Frontiers in microbiology vol. 8 (2017): 1320. doi: https://doi.org/10.3389/fmicb.2017.01320
Esquivel BD, White TC. Accumulation of Azole Drugs in the Fungal Plant Pathogen . Front Microbiol. 2017 Jul 13;8:1320. doi: 10.3389/fmicb.2017.01320. eCollection 2017. PMID: 28751884; PMCID: PMC5508014.
Copy Download .nbib Format: NLM
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.

Frontiers in pharmacology

Bellusci L, Laurino A, Sabatini M, Sestito S, Lenzi P, Raimondi L, Rapposelli S, Biagioni F, Fornai F, Salvetti A, Rossi L, Zucchi R, Chiellini G.
PMID: 29311919
Front Pharmacol. 2017 Dec 12;8:905. doi: 10.3389/fphar.2017.00905. eCollection 2017.

3-Iodothyronamine (T1AM) is an endogenous high-affinity ligand of the trace amine-associated receptor 1 (TAAR1), detected in mammals in many organs, including the brain. Recent evidence indicates that pharmacological TAAR1 activation may offer a novel therapeutic option for the treatment...

Cite
Bellusci L, Laurino A, Sabatini M, et al. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. Front Pharmacol. 2017;8:905doi: 10.3389/fphar.2017.00905.
Bellusci, L., Laurino, A., Sabatini, M., Sestito, S., Lenzi, P., Raimondi, L., Rapposelli, S., Biagioni, F., Fornai, F., Salvetti, A., Rossi, L., Zucchi, R., & Chiellini, G. (2017). New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. Frontiers in pharmacology, 8905. https://doi.org/10.3389/fphar.2017.00905
Bellusci, Lorenza, et al. "New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection." Frontiers in pharmacology vol. 8 (2017): 905. doi: https://doi.org/10.3389/fphar.2017.00905
Bellusci L, Laurino A, Sabatini M, Sestito S, Lenzi P, Raimondi L, Rapposelli S, Biagioni F, Fornai F, Salvetti A, Rossi L, Zucchi R, Chiellini G. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. Front Pharmacol. 2017 Dec 12;8:905. doi: 10.3389/fphar.2017.00905. eCollection 2017. PMID: 29311919; PMCID: PMC5732922.
Copy Download .nbib Format: NLM
Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells.

Neurochemistry international

Nagatsu T, Nakano T, Kato T, Higashida H.
PMID: 20487817
Neurochem Int. 1981;3(2):137-42. doi: 10.1016/0197-0186(81)90032-2.

Monoamine oxidase (MAO) activity towards kynuramine as substrate was measured in 6 hybrid cells derived by fusion of neuroblastoma and glioma, liver or brain cells, and was compared with that of parental or non-parental clones. Activities varied from the...

Cite
Nagatsu T, Nakano T, Kato T, et al. Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells. Neurochem Int. 1981;3(2):137-42doi: 10.1016/0197-0186(81)90032-2.
Nagatsu, T., Nakano, T., Kato, T., & Higashida, H. (1981). Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells. Neurochemistry international, 3(2), 137-42. https://doi.org/10.1016/0197-0186(81)90032-2
Nagatsu, T, et al. "Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells." Neurochemistry international vol. 3,2 (1981): 137-42. doi: https://doi.org/10.1016/0197-0186(81)90032-2
Nagatsu T, Nakano T, Kato T, Higashida H. Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells. Neurochem Int. 1981;3(2):137-42. doi: 10.1016/0197-0186(81)90032-2. PMID: 20487817.
Copy Download .nbib Format: NLM
Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.

BMC medical genomics

Zhao H, Flamand V, Peehl DM.
PMID: 19691856
BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.

BACKGROUND: Monoamine oxidase A (MAO-A), a mitochondrial enzyme that degrades monoamines including neurotransmitters, is highly expressed in basal cells of the normal human prostatic epithelium and in poorly differentiated (Gleason grades 4 and 5), aggressive prostate cancer (PCa). Clorgyline,...

Cite
Zhao H, Flamand V, Peehl DM. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009;2:55doi: 10.1186/1755-8794-2-55.
Zhao, H., Flamand, V., & Peehl, D. M. (2009). Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC medical genomics, 255. https://doi.org/10.1186/1755-8794-2-55
Zhao, Hongjuan, et al. "Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells." BMC medical genomics vol. 2 (2009): 55. doi: https://doi.org/10.1186/1755-8794-2-55
Zhao H, Flamand V, Peehl DM. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55. PMID: 19691856; PMCID: PMC2736984.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries